TREVENA INC
Pharmaceutical Preparations · 2870 PEACHTREE ROAD, SUITE 502, ATLANTA, GA 30305
官方登记数据
0位关注者
2007成立于
关于 TREVENA INC
Trevena, Inc. is a clinical stage biopharmaceutical company, headquartered in Chesterbrook, Pennsylvania, USA, and is involved in the discovery and development of G-protein coupled receptors (GPCR) biased ligands. Trevena was founded in 2007 with technology licensed from Duke University, which originated in the labs of company founders Robert Lefkowitz, winner of the 2012 Nobel Prize in Chemistry, and Howard Rockman. Trevena's approach to drug discovery is based on utilizing ligand bias, or functional selectivity, at GPCR targets to produce drugs with improved efficacy and reduced side effect profiles. Trevena was named one of the top 15 US startups of 2008 by Business Week.
Source: Wikipedia
行业Pharmaceutical Preparations
总部2870 PEACHTREE ROAD, SUITE 502, ATLANTA, GA 30305
成立2007
法律形式C Corporation
状态营业中
专利10 项专利
METHODS OF TREATING EPILEPSY USING THE SAMEJP2025138744A · 2025
COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAMEJP2023078375A · 2023
关键数据
法律信息
| 法定名称 | TREVENA INC |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1429560在 SEC EDGAR 上查看 ↗ |
| EIN | 26-1469215 |
| 行业代码(SIC) | 2834 |
| 注册地址 | 2870 PEACHTREE ROAD, SUITE 502, ATLANTA, GA 30305 |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Oct. 15, 2026
联系方式和链接
地点
2870 PEACHTREE ROAD, SUITE 502, ATLANTA, GA 30305
这是你的公司吗?
免费认领此页面,即可添加标志、产品、照片和职位,并回复评价。
认领此页面